|
|
||||||||
Ann Thorac Surg 2002;73:1071-1075
© 2002 The Society of Thoracic Surgeons
a Departments of Thoracic and Vascular Surgery, Kurobe, Japan
b Department of Radiology, Kurobe, Japan
c Department of Pathology, Kurobe City Hospital, Kurobe, Japan
Accepted for publication December 11, 2001.
* Address reprint requests to Dr Shun-ichi Watanabe, Department of Thoracic and Vascular Surgery, Kurobe City Hospital, Kurobe 938-8502, Japan
e-mail: shunuk{at}aol.com
| Abstract |
|---|
|
|
|---|
Methods. Between July 1996 and June 2001, 17 patients with localized BAC showing "pure GGA" (GGA without central scar formation) on thin-section CT underwent limited pulmonary resections. The mean patient age was 57.2 ± 10.5 years old. Among these patients, four tumors were detected in a CT mass-screening program and the others were incidentally detected on CT during follow-up for other diseases. Fourteen patients underwent thoracoscopic wedge resection, and 3 underwent segmentectomy because of tumor location.
Results. The mean tumor diameter was 7.9 ± 1.9 mm. On pathological examination, all tumors showed a pure bronchioloalveolar growth pattern and no evidence of stromal, vascular, or pleural invasion. The median follow-up time was 32.0 months, with no cancer death or relapse to date.
Conclusions. Focal BAC showing pure GGA on thin-section CT is peripheral in situ adenocarcinoma. Wedge resection by VATS is considered to be an appropriate treatment for this type of lung cancer. It can be a minimally invasive complete resection for this type of early cancer, and offer the best chance for long-term survival and good quality of life.
| Introduction |
|---|
|
|
|---|
| Patients and methods |
|---|
|
|
|---|
Preoperative investigations
When a round-shaped GGA without central scar formation was detected on thin-section CT (Fig 1),
repeat CT was performed 3 months later on suspicion of focal BAC. If the tumor size had increased or was unchanged, surgery was planned because of the high probability of BAC (Fig 2).
According to this management schedule, 20 patients agreed to surgery and underwent pulmonary resection. Among them, 17 patients were histopathologically revealed to have noninvasive BAC and 3 to have atypical adenomatous hyperplasia (AAH). Percutaneous biopsy was not attempted in our series. Preoperative staging included CT of the chest and abdomen in all patients, and there was no cervical mediastinoscopy employed. All tumors were indeterminate before surgery. The diagnosis was confirmed by frozen-section examination intraoperatively.
|
|
|
All values were expressed as means ± standard deviation (SD) throughout the article.
| Results |
|---|
|
|
|---|
|
Prognosis
All patients were discharged from hospital within 3 days after surgery without any complications. The follow-up periods have ranged from 4 to 62 months, the median follow-up period was 32.0 months. No postoperative death (including other causes of death) and cancer relapse has been detected to date.
| Comment |
|---|
|
|
|---|
The pathologic features of BAC are the presence of aerogenous spread and advance along the alveolar wall [12]. Eto and colleagues [13] classified BAC into two subtypes. In the early development of peripheral adenocarcinoma, there is preservation of the elastic network of the stroma due to contraction and thickening of the alveolar walls (type 1). As the tumor grows, the elastic framework is disrupted, indicating stromal invasion (type 2). Based on the clinicopathologic findings and outcome, type 1 tumor is considered in situ peripheral lung adenocarcinoma. In this article, we focused on the appropriateness of minimally invasive pulmonary resection for this type of lesion.
As for the detection of this lesion, all patients participating in this study were asymptomatic and detected by CT. Early detection and treatment are essential for improving the survival of lung cancer patients. In our series, four lesions were detected by a CT mass-screening program which we started in 1997. Sone and colleagues [14] reported that CT screening was an important investigation for the detection of early peripheral lung cancer. Patients with BAC in our series tended to be younger at diagnosis, were more likely to be female, and less likely to be cigarette smokers when compared with other patients with non-small cell lung cancer as previously described [10, 12, 15]. A CT screening program widely performed regardless of smoking history, age, or gender may be effective to detect early BAC and consequently reduce the death rate of lung cancer.
Lobectomy and regional lymph node dissection, termed "radical lobectomy," has been a standard surgery for lung cancer since Cahan [16] reported the first 48 cases successfully undergoing this procedure in 1960. However, this procedure can be an excessive resection for early lesions. Although sleeve bronchial resection has been accepted as a standard procedure for hilar early cancer, there is no standard limited resection for peripheral early cancer established to date. As the number of early-stage peripheral lung cancers is increasing, we consider that the surgical procedure for lung cancer should be tailored to each case. Trials of limited resection for lung cancer have already been undertaken [11, 17]. In lung parenchyma-preserving surgery, however, increased rates of recurrence and cancer death in the clinical stage I patients undergoing segmentectomy or wedge resection compared with those in patients undergoing lobectomy have been reported [18]. Therefore, sufficient criteria for limited resection have been explored in clinical stage I disease [19]. In this study, every BAC showing focal GGA on thin-section CT was revealed to be in situ adenocarcinoma by histopathological examination. We consider that wide-wedge resection by VATS would be a minimally invasive and curative surgery for this type of lung cancer as well as lung biopsy for indeterminate lesion.
Noguchi and colleagues [20] classified small adenocarcinoma into six subgroups (type A to F) according to the clinicopathological characteristics. Two of these six types, named type A (localized bronchioloalveolar carcinoma [LBAC]) and type B (LBAC with foci of alveolar structural collapse) showed a 100% 5-year survival after lobectomy with systematic nodal dissection and no lymph node metastasis. These types correspond to BAC without central scar formation as shown here and can be candidates for limited resection. This classification, however, was made postoperatively by microscopic pathological examination of tumors fixed in 10% formalin and embedded in paraffin after lobectomy. Therefore this technique is not very helpful in the surgical setting. This is the reason why we employed thin-section CT findings to preoperatively select candidates for limited resection in this study.
Among 20 patients operated upon for pure GGA lesion in our series, three patients were histopathologically revealed to be AAH as described. It appears to be difficult to discriminate AAH from noninvasive BAC preoperatively, because both lesions show the similar thin-section CT finding, focal round-shaped GGA without solid component. AAH was classified as a preinvasive lesion of adenocarcinoma by the World Health Organization in 1998 [21], for many investigators had provided evidence of a sequence from AAH to adenocarcinoma [22, 23]. Although AAH is not classified as a malignant lesion, wedge resection of this potential precursor lesion from which adenocarcinoma arises also seems to be an acceptable option.
The prognosis for BAC was originally thought to be poor. The lungs are the predominant sites of BAC recurrences, especially when BAC is of the pneumonic type [24]. However, more recent reports demonstrate a good prognosis for localized tumors [4, 25]. Breathnach and colleagues [10] described that stage I BAC are fourfold less prone to the development of extrathoracic disease. Our good results of wedge resection for BAC as described here support their opinion.
In conclusion, this study illustrates that focal BACs showing pure GGA on thin-section CT were histopathologically proven to be in situ adenocarcinomas. Wedge resection by VATS will achieve complete surgical resection of this type of early cancer, and offer the best chance for long-term survival and good quality of life. Detection and treatment of pure GGA lesions may improve a dismal prognosis of lung cancer.
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
E. Lim, D. Baldwin, M. Beckles, J. Duffy, J. Entwisle, C. Faivre-Finn, K. Kerr, A. Macfie, J. McGuigan, S. Padley, et al. Guidelines on the radical management of patients with lung cancer Thorax, October 1, 2010; 65(Suppl_3): iii1 - iii27. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. B. Godoy and D. P. Naidich Subsolid Pulmonary Nodules and the Spectrum of Peripheral Adenocarcinomas of the Lung: Recommended Interim Guidelines for Assessment and Management Radiology, December 1, 2009; 253(3): 606 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Koike, K.-i. Togashi, T. Shirato, S. Sato, H. Hirahara, M. Sugawara, F. Oguma, H. Usuda, and I. Emura Limited Resection for Noninvasive Bronchioloalveolar Carcinoma Diagnosed by Intraoperative Pathologic Examination Ann. Thorac. Surg., October 1, 2009; 88(4): 1106 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Infante, R. F. Lutman, S. Imparato, M. Di Rocco, G. L. Ceresoli, V. Torri, E. Morenghi, F. Minuti, S. Cavuto, E. Bottoni, et al. Differential diagnosis and management of focal ground-glass opacities Eur. Respir. J., April 1, 2009; 33(4): 821 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Goudarzi, H. A. Jacene, and R. L. Wahl Diagnosis and Differentiation of Bronchioloalveolar Carcinoma from Adenocarcinoma with Bronchioloalveolar Components with Metabolic and Anatomic Characteristics Using PET/CT J. Nucl. Med., October 1, 2008; 49(10): 1585 - 1592. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Kim, Y. M. Shim, K. S. Lee, J. Han, C. A Yi, and Y. K. Kim Persistent Pulmonary Nodular Ground-Glass Opacity at Thin-Section CT: Histopathologic Comparisons Radiology, October 1, 2007; 245(1): 267 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Wahidi, J. A. Govert, R. K. Goudar, M. K. Gould, and D. C. McCrory Evidence for the Treatment of Patients With Pulmonary Nodules: When Is It Lung Cancer?: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 94S - 107S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Arenberg Bronchioloalveolar Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 306S - 313S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Park, J. M. Goo, H. J. Lee, C. H. Lee, E. J. Chun, and J.-G. Im Nodular Ground-Glass Opacity at Thin-Section CT: Histologic Correlation and Evaluation of Change at Follow-up RadioGraphics, March 1, 2007; 27(2): 391 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Raz, B. He, R. Rosell, and D. M. Jablons Current concepts in bronchioloalveolar carcinoma biology. Clin. Cancer Res., June 15, 2006; 12(12): 3698 - 3704. [Full Text] [PDF] |
||||
![]() |
W. D. Travis, K. Garg, W. A. Franklin, I. I. Wistuba, B. Sabloff, M. Noguchi, R. Kakinuma, M. Zakowski, M. Ginsberg, R. Padera, et al. Evolving Concepts in the Pathology and Computed Tomography Imaging of Lung Adenocarcinoma and Bronchioloalveolar Carcinoma J. Clin. Oncol., May 10, 2005; 23(14): 3279 - 3287. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Watanabe, H. Asamura, K. Suzuki, and R. Tsuchiya The new strategy of selective nodal dissection for lung cancer based on segment-specific patterns of nodal spread Interact CardioVasc Thorac Surg, April 1, 2005; 4(2): 106 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sakurai, Y. Dobashi, E. Mizutani, H. Matsubara, S. Suzuki, K. Takano, S. Shindo, and M. Matsumoto Bronchioloalveolar Carcinoma of the Lung 3 Centimeters or Less in Diameter: A Prognostic Assessment Ann. Thorac. Surg., November 1, 2004; 78(5): 1728 - 1733. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Meyer, R. T. Shipley, K. S. Lee, T. Johkoh, and R. Kakinuma Invited Commentary * Authors' Response RadioGraphics, November 1, 2004; 24(6): 1632 - 1636. [Full Text] [PDF] |
||||
![]() |
S. Yamada and T. Kohno Video-assisted thoracic surgery for pure ground-glass opacities 2 cm or less in diameter Ann. Thorac. Surg., June 1, 2004; 77(6): 1911 - 1915. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sawabata, M. Ohta, A. Matsumura, K. Nakagawa, H. Hirano, H. Maeda, and H. Matsuda Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study Ann. Thorac. Surg., February 1, 2004; 77(2): 415 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Barlesi, C. Doddoli, J.-P. Kleisbauer, and P. Thomas Reply to Johnson Eur J Cardiothorac Surg, January 1, 2004; 25(1): 148 - 148. [Full Text] [PDF] |
||||
![]() |
F. Barlesi, C. Doddoli, C. Gimenez, B. Chetaille, R. Giudicelli, P. Fuentes, J.-P. Kleisbauer, and P. Thomas Bronchioloalveolar carcinoma: myths and realities in the surgical management Eur J Cardiothorac Surg, July 1, 2003; 24(1): 159 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Watanabe, M. Oda, Y. Tsunezuka, T. Go, Y. Ohta, and G. Watanabe Peripheral small-sized (2 cm or less) non-small cell lung cancer with mediastinal lymph node metastasis; clinicopathologic features and patterns of nodal spread Eur J Cardiothorac Surg, December 1, 2002; 22(6): 995 - 999. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |